COVID-19 in heart transplant recipients

COVID-19 in heart transplant recipients

Blog Article

Introduction: After solid organ transplantation, patients require lifelong immunosuppressive medication, increasing susceptibility to COVID-19.We evaluated the clinical outcomes of heart transplant recipients in patients with metabo 15-gauge finish nailer cordless COVID-19.Methods: We enrolled twenty-two COVID-19 cases of adult heart transplantation from February 2020 to September 2021.

Results: The most common symptoms in patients were fever and myalgia.The death occurred in 3 (13.6 %).

Conclusion: Although heart transplantation mortality may increase in the acute rejection phase concomitant with COVID-19, immunosuppressive galaxy harmony nc dose reduction may not be necessary for all heart transplant patients with COVID-19.